Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML). (Record no. 28740924)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02082 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517233130.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201904s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1873-5835 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.leukres.2018.08.005 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Zeidner, Joshua F |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190403 |
| 245 00 - TITLE STATEMENT | |
| Title | Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML). |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Leukemia research |
| Date of publication, distribution, etc. | 09 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 92-95 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Comparative Study; Letter; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytarabine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Daunorubicin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Flavonoids |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mitoxantrone |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperidines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Risk Factors |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Foster, Matthew C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blackford, Amanda L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Litzow, Mark R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morris, Lawrence E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Strickland, Stephen A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lancet, Jeffrey E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bose, Prithviraj |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Levy, M Yair |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tibes, Raoul |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gojo, Ivana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gocke, Christopher D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rosner, Gary L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Little, Richard F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wright, John J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Doyle, L Austin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smith, B Douglas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Karp, Judith E |
| 773 0# - HOST ITEM ENTRY | |
| Title | Leukemia research |
| Related parts | vol. 72 |
| -- | p. 92-95 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.leukres.2018.08.005">https://doi.org/10.1016/j.leukres.2018.08.005</a> |
| Public note | Available from publisher's website |
No items available.